155 related articles for article (PubMed ID: 18172260)
21. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.
Radhakrishnan A; Badhrinarayanan N; Biswas J; Krishnakumar S
Mol Vis; 2009 Oct; 15():2146-54. PubMed ID: 19898689
[TBL] [Abstract][Full Text] [Related]
22. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract][Full Text] [Related]
23. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.
Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C
J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
26. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution.
Höglund M; Gisselsson D; Hansen GB; White VA; Säll T; Mitelman F; Horsman D
Int J Cancer; 2004 Jan; 108(1):57-65. PubMed ID: 14618616
[TBL] [Abstract][Full Text] [Related]
27. Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival.
White JS; McLean IW; Becker RL; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Oct; 170(1):29-39. PubMed ID: 16965952
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetics of iris melanomas: disparity with other uveal tract melanomas.
Sisley K; Brand C; Parsons MA; Maltby E; Rees RC; Rennie IG
Cancer Genet Cytogenet; 1998 Mar; 101(2):128-33. PubMed ID: 9494614
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
Gill HS; Char DH
Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
[TBL] [Abstract][Full Text] [Related]
30. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
31. Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Kucherlapati M
BMC Cancer; 2018 Aug; 18(1):818. PubMed ID: 30107825
[TBL] [Abstract][Full Text] [Related]
32. Assessing Prognosis in Uveal Melanoma.
Correa ZM
Cancer Control; 2016 Apr; 23(2):93-8. PubMed ID: 27218785
[TBL] [Abstract][Full Text] [Related]
33. [Genomic profiling by comparative genomic hybridization: analysis of ten enucleated uveal melanoma cases].
Abi-Ayad N; Couturier J; Devouassoux-Shisheboran M; Grange JD; Kodjikian L; Calender A
J Fr Ophtalmol; 2011 Jan; 34(1):17-23. PubMed ID: 21145127
[TBL] [Abstract][Full Text] [Related]
34. Unique genomic profile associated with pediatric uveal melanoma.
Blasi MA; Orteschi D; Pagliara MM; Coco G; Asaro A; Mulè A; Petrone G; Zollino M
Eur J Ophthalmol; 2015; 25(4):e31-4. PubMed ID: 25790812
[TBL] [Abstract][Full Text] [Related]
35. Genomic identification of significant targets in ciliochoroidal melanoma.
McCannel TA; Burgess BL; Nelson SF; Eskin A; Straatsma BR
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3018-22. PubMed ID: 20688739
[TBL] [Abstract][Full Text] [Related]
36. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
[TBL] [Abstract][Full Text] [Related]
37. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
[TBL] [Abstract][Full Text] [Related]
39. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma.
Tschentscher F; Prescher G; Horsman DE; White VA; Rieder H; Anastassiou G; Schilling H; Bornfeld N; Bartz-Schmidt KU; Horsthemke B; Lohmann DR; Zeschnigk M
Cancer Res; 2001 Apr; 61(8):3439-42. PubMed ID: 11309305
[TBL] [Abstract][Full Text] [Related]
40. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review.
Berus T; Halon A; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P
Anticancer Res; 2017 Dec; 37(12):6541-6549. PubMed ID: 29187428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
